This compound is a pharmaceutical intermediate specifically designed for the synthesis of adenosine analogs. It features a purine ring system with an iodine substituent and multiple polar functional groups, making it a key building block in nucleoside analog manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
NECA
pharmaceutical raw material
Gs-9667
pharmaceutical intermediate
8-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one
pharmaceutical intermediate
TERT-BUTYL N-[(1S)-1-(BENZYLCARBAMOYL)-2-HYDROXYETHYL]CARBAMATE
pharmaceutical intermediate
(R)-Tetrahydropapaverine N-acetyl-L-leucinate
pharmaceutical intermediate
(1S,4R)-4-[(2,5-Diamino-6-chloro-4-pyrimidinyl)amino]-2-cyclopentene-1-methanol
pharmaceutical intermediate
(2S,3S,4R,5R)-5-(6-amino-2-iodopurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide
YEBHQRSEUJCFMN-QMWPFBOUSA-N
CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)I)N)O)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.